JPM26: Boston Scientific acquires Penumbra in $14.5bn deal
Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech giant’s offerings in ‘fast-growing segments’ within the vascular care space. Under the deal, Boston will inherit Penumbra products, …